Search Orphan Drug Designations and Approvals
-
Generic Name: | cereblon enzyme 3 (E3) ligase modulating agent |
---|---|
Date Designated: | 03/25/2021 |
Orphan Designation: | Treatment of acute myeloid leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Celgene Corporation (a Bristol-Myers Squibb Company) 86 Morris Avenue Summit, New Jersey 07901 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-